Health In Tech, Inc.
Severe listing-compliance risk
The share price is below $1 and the stored reverse-split/listing-risk level is HIGH. No verified reverse-split authorization or announced reverse split is currently recorded. This is a risk signal, not confirmation that Nasdaq has issued a deficiency notice.
HIT · Price history
Price at last available close
$0.65
−$0.20 (-23.77%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Health In Tech, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 13, 2026. A research update is not a new financial filing.
Who they are
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses.
How they make money
Health In Tech operates an AI-enabled InsurTech marketplace that facilitates the sale of self-funded health benefits plans to small businesses. The company generates revenue by providing a platform where licensed brokers can select and sell various insurance products, including reference-based pricing, group insurance captives, and association health programs, simplifying the administrative processes for small business health coverage.
Products & services
AI-enabled insurance technology platform offering reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Strengths
Risks
- High healthcare costs and low value of health benefits for small businessesSource
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Quarterly EPS turned negative at -0.04 versus 0.01 a year earlier.
Separate recurring operating losses from noncash or one-time charges, and check cash flow rather than interpreting negative EPS as a cash-outflow amount.
Quarterly net income turned from a profit to a loss versus the same quarter last year.
Identify the causes in the interim report and distinguish operating cash use from accounting charges. Prior profitability is not a guarantee of recovery.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
44
Weak
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
68
Fair
Financial Strength
63
Business Quality / Moat
100
Management
58
Growth Quality
42
Risk / Durability
67
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
23
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
38/100
Building Historical Record
Model Score 38/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
Reverse-split / listing-compliance risk: HIGH
This is a risk signal, not a prediction. It is separate from Wall Street Score and does not change the company score. It looks for listing-pressure signals such as prolonged Nasdaq trading below $1, very low share price, micro-cap size, negative free cash flow, and verified recent reverse splits.
Risk indicator: 55/100
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Asset quality scores strongly
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for HIT
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving HIT's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can HIT fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is HIT likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for HIT to reach sustainable profitability?
- •What future growth or profitability would be needed to justify HIT's current valuation?
Essential Investment Snapshot
Wall Street Score
44
Opportunity Score
23
Market Cap
$34.8M
P/E Ratio
-11.6
EPS
$-0.07
52-Week High
$4.02
52-Week Low
$0.77
Beta
2.73
Analyst Target
$3.50
Shares Outstanding
57.7M
Total Revenue
$32.8M
Total Debt
$103K
Dividend
No current dividend
Liquidation Value / Share
$0.34
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Extreme movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Community Sentiment
0 active · 0 total callsNo personal call yet on HIT.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +AI-enabled platform for process simplification and automation.
- +Vertical integration within the healthcare industry.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Software - Application industry.
- −High healthcare costs and low value of health benefits for small businesses.
- −Negative free cash flow may increase the need for outside financing and dilution.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
4 historical score records availablePrevious Score
44
Sep 28, 2026
Change
+0.3
points
Current Score
44
Oct 1, 2026
Category Changes
HIT increased 0.3 points because overall fundamentals improved.
Projected Score
Projected Score
35
Projected Change
-9.2 points
Preliminary comparable-period financial changes suggest decline of approximately 9.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$0.65
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Large reported revenue change: +71.0%
Revenue changed sharply from 2024 to 2025. This can reflect a real business change, acquisition, divestiture, discontinued operations, restatement, or reporting-basis change. Compare the underlying filing before treating it as normal growth or decline.
TTM may combine quarters from before and after the event, so its trend can also be distorted.
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $32.8M | $33.3M | $19.5M | $19.2M | ···· |
| Cost of Revenue | $15.1M | $12.4M | $4.1M | $2.3M | ···· |
| Gross Profit | $17.7M | $20.9M | $15.4M | $16.8M | ···· |
| Research & Development | $2.2M | $1.6M | $2.8M | $2.0M | ···· |
| SG&A Expenses | $20.7M | $17.8M | $11.6M | $11.5M | ···· |
| Operating Expenses | $23.0M | $19.4M | $14.4M | $13.5M | ···· |
| EBITDA | -$4.4M | $2.6M | $1.9M | $3.8M | ···· |
| Operating Income | -$5.3M | $1.5M | $990K | $3.4M | ···· |
| Interest Expense | $0.00 | $0.00 | $495K | $2K | ···· |
| Income Before Tax | -$5.2M | $1.7M | $889K | $3.4M | ···· |
| Income Tax Expense | -$1.3M | $395K | $219K | $945K | ···· |
| Net Income | -$3.9M | $1.3M | $670K | $2.5M | ···· |
| Basic EPS | $-0.07 | $0.02 | $0.01 | $0.05 | ···· |
| Basic Shares | 62.83M | 55.84M | 53.66M | 54.07M | ···· |
| Diluted Shares | 62.83M | 57.74M | 53.66M | 54.07M | ···· |
Earnings Summary
Revenue
$8.1M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.04
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-41.0%
Cash Change
-19.9%
Margin Change
-37.9 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Debt reduced
What Weakened
- Margins contracted
- Cash position declined
Potential Score Impact
Positive indicators included debt levels. Pressure indicators included revenue growth, EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 13.5%. EPS declined 500.0%. Cash declined 19.9%. Total debt declined 41.0%. Net income margin declined by 37.9 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
4 historical recordsHistorical Score Chart
3 of 4 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Software - ApplicationNews
Health In Tech to Host Annual Meeting of Stockholders
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
Rumor Mill · HIT
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial